Fueling Early Tumorigenesis: Interplay Between the Exposome, Obesity-Driven Metabolic Dysfunction and Early-Onset Colorectal and Breast Cancer

Clicks: 18
ID: 328769
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #38 of 56 articles by views in journal of carcinogenesis

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Early-onset cancers (EOCs), defined as cancers diagnosed before the age of 50, are increasing globally. This rise cannot be fully explained by improved detection, suggesting the involvement of evolving environmental and lifestyle-related risk factors. In parallel, the global prevalence of obesity has increased substantially, particularly among younger populations. Obesity is increasingly recognized not simply as excess adiposity, but as a systemic metabolic state characterized by insulin resistance, hyperinsulinemia, chronic low-grade inflammation, altered lipid metabolism, hormonal dysregulation, microbiome disruption, and epigenetic remodeling. These perturbations create a pro-tumorigenic environment that may promote early tumor initiation and progression. Importantly, when metabolic dysfunction arises during critical developmental windows, including in utero, childhood, adolescence, and early adulthood, it may establish long-lasting biological programs that influence growth signaling, immune function, and tissue homeostasis. In this context, increasing attention has shifted toward the "exposome," defined as the totality of environmental exposures encountered across the lifespan and their interactions with biological susceptibility. These exposures may contribute to obesity-associated metabolic dysfunction and interact with one another to influence cancer risk, underscoring the multifactorial nature of EOC development. In this review, we integrate epidemiologic and mechanistic evidence linking obesity and metabolic dysfunction to EOCs, with a focus on colorectal and breast cancers. We highlight key biological pathways, including metabolic signaling, inflammation, microbiome alterations, endocrine disruption, and epigenetic reprogramming, and discuss emerging strategies for prevention and early risk stratification. Understanding the interplay between metabolic health and the exposome may provide critical insights into the prevention of EOCs in younger populations.
Reference Key
openalex_W7213225409 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mansi Upadhyay, Arianna V Bastian, Thomas D. Cardaci, Minjung Kim, Liza Makowski, Susan E. Steck, E. Angela Murphy
Journal journal of carcinogenesis
Year 2026
DOI
10.1093/carcin/bgag063
URL
https://doi.org/10.1093/carcin/bgag063
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.